Lipid extract from blue mussel (Mytilus edulis) improves glycemic traits in Chinese type 2 diabetic mellitus patients: a double-blind randomized controlled trial.

Xiaotong KuangXianfeng ShaoHuiying LiDongmei JiangTianlin GaoJie YangKelei LiDuo Li

Published in: Journal of the science of food and agriculture (2022)

Blue mussel lipid supplements improved glycemic traits, inflammatory cytokines, and lipids profile in Chinese T2DM patients (Chinese Clinical Trial Registration number: ChiCTR1900025617). © 2022 Society of Chemical Industry.

Keyphrases

randomized controlled trial
end stage renal disease
clinical trial
type diabetes
ejection fraction
chronic kidney disease
newly diagnosed
study protocol
prognostic factors
systematic review
patient reported outcomes
fatty acid
metabolic syndrome
glycemic control
phase ii
weight loss
phase iii